<DOC>
	<DOCNO>NCT01786902</DOCNO>
	<brief_summary>Growth hormone therapy improve height idiopathic short statured child . DA-3002 ( Recombinant Human Growth hormone ) treat group 26 week , compare non-treatment group efficacy safety .</brief_summary>
	<brief_title>Efficacy Safety DA-3002 Children With Idiopathic Short Stature</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Chronological Age â‰¥ 4 Bone Age &lt; 11 ( girl ) &lt; 13 ( boy ) Height &lt; 3rd percentile age normal thyroid function endocrine and/or metabolic disorder growth failure cause disorder previous use drug could interfere Growth Hormone treatment</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>growth hormone</keyword>
</DOC>